AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
Lasersailor21 - Author Avatar

Lasersailor21

Lasersailor21
Lasersailor21 3h ago
$COST $KWEB $WMT 😳😳😳WOOW😳😳👇🏻👇🏻👇🏻 Nnn
post-image-1024f472bc2c23444913
COST--
KWEB--
WMT--
Lasersailor21
Lasersailor21 4h ago
$GMEGME--
constructiontimeagnn
constructiontimeagnn 3h ago

From an allocation lens, I’m treating GME as a speculative satellite: tiny weight, no duration, hedged with cash and puts. If it rallies, I’ll rotate a bit into SPY; if it dumps, I’ll trim and wait.

Mowag
Mowag 4h ago

Seen this movie before—meme mania fades, but disciplined holders usually ride through. GME’s volatility is exhausting, yet the fundamentals linger.

xtreem_neo
xtreem_neo 4h ago

Anyone else think this is just hype again?

Lasersailor21
Lasersailor21 7h ago
$PFE Happy we're only down 8% after our beat and raise. It's been the 12th one in a rowPFE--
Lasersailor21
Lasersailor21 Yesterday
$ORCL. Emotional selling is over. Shorts have crushed this stock. At these levels, a sharp V-shaped bounce is due. Earnings will once again beat expectations. My prediction: 120% upside by 2027.ORCL--
Lasersailor21
Lasersailor21 Yesterday
$TLT May not be flashy but at least our CEO isn't facing issues with SEC and National SecurityTLT--
jeffreyc96
jeffreyc96 Yesterday

I’m still holding TLT and a small TIP sleeve, but I’m uneasy. If rates stay higher for longer, I might trim and rotate into cash or short-duration until clarity.

Loud_Ad_6880
Loud_Ad_6880 Yesterday

Buying dips, but watching for policy whiplash.

Brolegz
Brolegz Yesterday

Feels like every time we think bonds are stable, some headline pops up. Regulators, inflation fears, and election chatter keep flipping the script. I’m tired of chasing reassurance.

Lasersailor21
Lasersailor21 Yesterday
$MSOS Trlv dropping $10 again is really disappointing. This stock has been near the upper trend line for 4 years. Recently, it went above that line, only to be pushed back down after a price increase and being added to the Russell index. It's really frustrating. Maybe those who say we need more institutional money are right. Until the Russell actually buys shares, it all seems pointless.MSOS--
TRLV--
Antinetdotcom
Antinetdotcom Yesterday

Watching MSOS, not in yet; feels choppy.

0nlyGoesUp
0nlyGoesUp Yesterday

As a sector watcher, MSOS’s volatility mirrors broader mid-cap tech. Until Russell flows materialize, rallies feel fragile and trendlines keep getting tested.

Gwuana
Gwuana Yesterday

Everyone’s frustrated, but I’m oddly calm. A pullback to trend line often sets up a squeeze. Feels like the market’s overreacting.

Lasersailor21
Lasersailor21 11/16
$SMCI market cap is now 15 billion 😂
post-image-10248b45c5dbeeb81cff
SMCI--
TendieDippedDiamonds
TendieDippedDiamonds 11/16

Anyone else feel weird seeing SMCI at $15B?

sgkakilang
sgkakilang 11/16

Seen this movie with NVDA and AMZN before—market caps can rocket, then grind. Feels exciting, but patience matters.

WhoreMasterFalco
WhoreMasterFalco 11/16

SMCI at $15B implies ~$150/share if 100M float, but trailing P/E is ~40x and free cash flow yield barely 2%. That’s not sustainable without massive revenue growth or margin improvement.

Lasersailor21
Lasersailor21 11/16
$INTC took a position after hours boys what's nextINTC--
tempestlight
tempestlight 11/16

Everyone’s reading this as panic, but I think it’s the opposite: disciplined sizing after a messy quarter. If they’re buying puts, they’re hedging, not capitulating. Feels like sanity amid noise.

Hopeful_Confusion870
Hopeful_Confusion870 11/16

For those holding long term, how are you adjusting? Are you adding on this volatility, or waiting for clearer guidance? What’s your thesis on cloud mix, AI spend, and margins given this after-hours move?

WeightNeat
WeightNeat 11/16

Feels like a micro-cap hedge: INTX buying puts while $INTC stays long. Position sizing looks cautious, not panicked.

Lasersailor21
Lasersailor21 11/16
$SPY just some green but the VIXSPY--
Lasersailor21
Lasersailor21 11/15
$SLS $MRNA $XBI $ABBV https://www.mdpi.com/2072-6694/15/5/1458 IDMC Unblinded Phase 3 REGAL Trial Results: • 80% of Gps Patients Show Immune Response Linked to Better Survival in Past Trials. Cancer 2023 Submission: 19 Jan 2023 / Revised: 19 Feb 2023 / Accepted: 22 Feb 2023 / Published: 25 Feb 2023
post-image-1024891e35a9d548c9a9
ABBV--
MRNA--
SLS--
XBI--
Scroll to load more